|2005N-0345|| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product|
|FDA Comment Number :||EC933|
|Submitter :||Dr. Daniel Pomerantz||Date & Time:||10/27/2005 08:10:06|
|Organization :||Dr. Daniel Pomerantz|
|Category :||Health Professional|
| I am writing to voice my concern about the FDA's failure to make a decision on the application to make Plan B emergency contraception (EC) available over the counter.
Unintended pregnancy is a significant public health problem in the United States, and women deserve a chance to prevent it. Plan B is a safe, effective, and easy-to-use contraceptive option that will help reduce the need for abortion.
I urge the FDA to grant Plan B over-the-counter status for all women.